Berns, E M <br/><br/>
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 1998 
 - 121-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1998.16.1.121  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Breast Neoplasms--chemistry<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Proteins--metabolism<br/>Neoplasm Recurrence, Local--metabolism<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Regression Analysis<br/>Survival Analysis<br/>Tamoxifen--therapeutic use<br/>Tumor Suppressor Protein p53--metabolism